News FDA approves expanded use for GSK's COPD triple therapy GSK is aiming to revive its respiratory drugs franchise
News GSK sells rare disease drugs, including groundbreaking Strim... CEO Walmsley opts to focus on blockbuster medicines
Market Access Verona to take COPD hopeful into phase 3 Verona Pharma is to take lung drug RPL554 into late clinical development after a successful phase 2b trial.
News GSK to pay $13bn for Novartis stake in OTC joint venture GlaxoSmithKline is to buy out Novartis from their over-the-counter joint venture, and may sell its Horlicks business to fund the £9.2 billion ($13bn) acquisition.
News GSK left as sole bidder for Pfizer consumer health unit GSK is left as sole bidder amid speculation that the sale is off.
News GSK's Luke Miels demands new focus, and cost cuts Further details have emerged about GlaxoSmithKline’s attempts to reinvigorate its business under new CEO Emma Walmsley.
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
